English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine Healthcare & Pharm
Formerra to Supply Foster Medical Compounds Across the Americas
Jul 15, 2025 22:50 HKT
雲頂新耀股價創階段新高 通用型現貨腫瘤治療性疫苗EVM14「中美雙報」再釋mRNA平台潛力
Jul 15, 2025 17:40 HKT
云顶新耀股价创阶段新高 通用型现货肿瘤治疗性疫苗EVM14"中美双报"再释mRNA平台潜力
Jul 15, 2025 17:34 HKT
耀啟新程!康哲藥業今日於新加坡交易所主板實現二次上市
Jul 15, 2025 17:05 HKT
耀启新程!康哲药业今日于新加坡交易所主板实现二次上市
Jul 15, 2025 16:53 HKT
AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Disease
Jul 15, 2025 16:00 HKT
康诺思腾自主创新研发的手术机器人 成功于英国启动首轮临床试验
Jul 09, 2025 20:35 HKT
Cornerstone Robotics Launches First Clinical Evaluation of its Hong Kong-Developed Surgical Robotic System in UK
Jul 09, 2025 20:32 HKT
康諾思騰自主創新研發的手術機械人 成功於英國啟動首輪臨床試驗
Jul 09, 2025 20:32 HKT
Everest Medicines Unveils Breakthroughs in AI+mRNA Platform, Reinforces Global Leadership in Next-Gen mRNA Innovation
Jul 04, 2025 18:59 HKT
雲頂新耀發佈AI+mRNA平台新突破 重塑中國mRNA國際競爭格局
Jul 04, 2025 18:52 HKT
云顶新耀发布AI+mRNA平台新突破 重塑中国mRNA国际竞争格局
Jul 04, 2025 18:40 HKT
雲頂新耀公佈EVER001-1b/2a期階段性數據 專家看好其作為新一代BTK療法的潛力
Jul 03, 2025 19:22 HKT
云顶新耀公布EVER001-1b/2a期阶段性数据 专家看好其作为新一代BTK疗法的潜力
Jul 03, 2025 17:52 HKT
瑞爾集團公佈2025財年業績報告
Jun 30, 2025 10:43 HKT
瑞尔集团公布2025财年业绩报告
Jun 30, 2025 10:29 HKT
Silo Pharma Enters Letter of Intent for JV with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market

Jun 25, 2025 21:27 HKT
康哲藥業建議於新加坡交易所第二上市
Jun 25, 2025 18:13 HKT
China Medical System Holdings Limited: Proposed Secondary Listing on the Singapore Exchange
Jun 25, 2025 18:00 HKT
康哲药业建议于新加坡交易所第二上市
Jun 25, 2025 17:24 HKT
<< Previous  Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: